AI Article Synopsis
- Deregulation of chromatin modifiers, like DNA helicases, plays a key role in the transformation of ALK-negative anaplastic large cell lymphoma (ALCL).
- Researchers identified the DNA helicase HELLS as crucial for the growth and progression of ALK-ALCL and explored its functions through RNA sequencing.
- HELLS works with the transcription factor YY1 to regulate genes essential for cell division, specifically targeting RhoA and RhoU, which are involved in cell proliferation and division in ALK-ALCLs.
Article Abstract
Deregulation of chromatin modifiers, including DNA helicases, is emerging as one of the mechanisms underlying the transformation of anaplastic lymphoma kinase negative (ALK) anaplastic large cell lymphoma (ALCL). We recently identified the DNA-helicase HELLS as central for proficient ALKALCL proliferation and progression. Here we assessed in detail its function by performing RNA-sequencing profiling coupled with bioinformatic prediction to identify HELLS targets and transcriptional cooperators. We demonstrated that HELLS, together with the transcription factor YY1, contributes to an appropriate cytokinesis via the transcriptional regulation of genes involved in cleavage furrow regulation. Binding target promoters, HELLS primes YY1 recruitment and transcriptional activation of cytoskeleton genes including the small GTPases RhoA and RhoU and their effector kinase Pak2. Single or multiple knockdowns of these genes reveal that RhoA and RhoU mediate HELLS effects on cell proliferation and cell division of ALKALCLs. Collectively, our work demonstrates the transcriptional role of HELLS in orchestrating a complex transcriptional program sustaining neoplastic features of ALKALCL.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840974 | PMC |
| http://dx.doi.org/10.1038/s41419-021-03425-0 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
CDCA7 is an evolutionarily conserved hemimethylated DNA sensor in eukaryotes.
Sci Adv
August 2024
Laboratory of Chromosome and Cell Biology, The Rockefeller University, New York, NY 10065, USA.
Mutations of the SNF2 family ATPase HELLS and its activator CDCA7 cause immunodeficiency, centromeric instability, and facial anomalies syndrome, characterized by DNA hypomethylation at heterochromatin. It remains unclear why CDCA7-HELLS is the sole nucleosome remodeling complex whose deficiency abrogates the maintenance of DNA methylation. We here identify the unique zinc-finger domain of CDCA7 as an evolutionarily conserved hemimethylation-sensing zinc finger (HMZF) domain.
View Article and Find Full Text PDFThe C-terminal 4CXXC-type zinc finger domain of CDCA7 recognizes hemimethylated DNA and modulates activities of chromatin remodeling enzyme HELLS.
Nucleic Acids Res
September 2024
Cellular Memory Laboratory, RIKEN Cluster for Pioneering Research, Wako City, Saitama 351-0198, Japan.
The chromatin-remodeling enzyme helicase lymphoid-specific (HELLS) interacts with cell division cycle-associated 7 (CDCA7) on nucleosomes and is involved in the regulation of DNA methylation in higher organisms. Mutations in these genes cause immunodeficiency, centromeric instability, and facial anomalies (ICF) syndrome, which also results in DNA hypomethylation of satellite repeat regions. We investigated the functional domains of human CDCA7 in HELLS using several mutant CDCA7 proteins.
View Article and Find Full Text PDFHELLS regulates transcription in T-cell lymphomas by reducing unscheduled R-loops and by facilitating RNAPII progression.
Nucleic Acids Res
June 2024
Laboratory of Translational Research, Azienda USL-IRCCS di Reggio Emilia, Viale Risorgimento 80, 42123, Reggio Emilia, Italy.
Chromatin modifiers are emerging as major determinants of many types of cancers, including Anaplastic Large Cell Lymphomas (ALCL), a family of highly heterogeneous T-cell lymphomas for which therapeutic options are still limited. HELLS is a multifunctional chromatin remodeling protein that affects genomic instability by participating in the DNA damage response. Although the transcriptional function of HELLS has been suggested, no clues on how HELLS controls transcription are currently available.
View Article and Find Full Text PDFIdentification of MCM4 and PRKDC as new regulators of osteosarcoma cell dormancy based on 3D cell cultures.
Biochim Biophys Acta Mol Cell Res
March 2024
Nantes Université, CNRS, US2B, UMR 6286, 44000 Nantes, France; Institut de Cancérologie de l'Ouest, Tumor Heterogeneity and Precision Medicine Lab., 44805 Saint-Herblain, France; Department of Oncology and Metabolism, Medical School, University of Sheffield, Sheffield, UK. Electronic address:
Dormancy is a potential way for tumors to develop drug resistance and escape treatment. However, the mechanisms involved in cancer dormancy remain poorly understood. This is mainly because there is no in vitro culture model making it possible to spontaneously induce dormancy.
View Article and Find Full Text PDFCoevolution of the CDCA7-HELLS ICF-related nucleosome remodeling complex and DNA methyltransferases.
Elife
September 2023
Bioinformatics Resource Center, The Rockefeller University, New York, United States.
Article Synopsis
- 5-Methylcytosine (5mC) and DNA methyltransferases (DNMTs) play essential roles in maintaining DNA methylation across eukaryotes, but these mechanisms can be lost through evolution.
- Mutations in genes like HELLS and CDCA7, along with the DNA methyltransferase DNMT3B, are linked to ICF syndrome, which results in reduced DNA methylation.
- The study explores the coevolution of CDCA7, HELLS, and DNMTs, showing that their presence tends to be conserved in certain species while frequently lost in others, hinting at their critical interdependence in maintaining DNA methylation.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!